Abstract
Considerable concern and confusion exists about Medication-Related OsteoNecrosis of the Jaw (MRONJ) which can be a painful, prolonged and debilitating condition caused by the death of jaw bone. The most common class of drugs causing this rare problem is the bisphosphonate group of drugs, which resulted in the term Bisphosphonate-Related OsteoNecrosis of the Jaw previously being given the acronym BRONJ. CPD/Clinical Relevance: This article will help to update healthcare practitioners on assessing the realistic risks of patients developing MRONJ. It offers some ideas on reducing those risks in a practical way.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
